83004-015-01 : NDC 2026 Code

83004-015-01 : Lactic Acid, Boric Acid, Chlorhexidine Gluconate, Cnidium Monnieri Fruit, Levomenol ( Medicated Foaming Feminine )

Additionally :

You can get information about “83004-015-01” NDC code in 83004-015-01 in HTML format

HTML | 83004-015-01 in TXT (Plain Text) format

TXT | 83004-015-01 in PDF (Portable Document Format)

PDF | 83004-015-01 in XML format

XML formats.

NDC Code : 83004-015-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "83004-015-01",
    "PackageDescription": "1 BOTTLE in 1 BOX (83004-015-01)  / 150 mL in 1 BOTTLE",
    "NDC11Code": "83004-0015-01",
    "ProductNDC": "83004-015",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Medicated Foaming Feminine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Lactic Acid, Boric Acid, Chlorhexidine Gluconate, Cnidium Monnieri Fruit, Levomenol",
    "DosageFormName": "GEL",
    "RouteName": "TOPICAL",
    "StartMarketingDate": "20250227",
    "EndMarketingDate": null,
    "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
    "ApplicationNumber": null,
    "LabelerName": "Rida LLC",
    "SubstanceName": "BORIC ACID; CHLORHEXIDINE GLUCONATE; CNIDIUM MONNIERI FRUIT OIL; LACTIC ACID; LEVOMENOL",
    "StrengthNumber": ".5; 1; .5; .5; .3",
    "StrengthUnit": "g/100mL; g/100mL; g/100mL; g/100mL; g/100mL",
    "Pharm_Classes": "Acidifying Activity [MoA], Decreased Cell Wall Integrity [PE]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-03-08",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250227",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}